A detailed history of Susquehanna International Group, LLP transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 35,056 shares of IDYA stock, worth $934,592. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,056
Previous 29,555 18.61%
Holding current value
$934,592
Previous $1.04 Million 7.04%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.37 - $43.05 $167,065 - $236,818
5,501 Added 18.61%
35,056 $1.11 Million
Q2 2024

Aug 15, 2024

SELL
$34.37 - $43.46 $276,815 - $350,026
-8,054 Reduced 21.42%
29,555 $1.04 Million
Q1 2024

May 07, 2024

BUY
$34.2 - $47.13 $236,219 - $325,526
6,907 Added 22.5%
37,609 $1.65 Million
Q4 2023

Feb 14, 2024

BUY
$24.59 - $35.83 $279,588 - $407,387
11,370 Added 58.81%
30,702 $1.09 Million
Q3 2023

Nov 14, 2023

SELL
$21.07 - $29.77 $374,266 - $528,804
-17,763 Reduced 47.89%
19,332 $521,000
Q2 2023

Aug 11, 2023

SELL
$13.33 - $25.53 $357,350 - $684,408
-26,808 Reduced 41.95%
37,095 $871,000
Q1 2023

May 16, 2023

BUY
$13.49 - $18.72 $691,888 - $960,130
51,289 Added 406.6%
63,903 $877,000
Q4 2022

Feb 14, 2023

SELL
$14.47 - $18.17 $443,635 - $557,074
-30,659 Reduced 70.85%
12,614 $229,000
Q3 2022

Nov 14, 2022

BUY
$9.24 - $15.79 $86,209 - $147,320
9,330 Added 27.49%
43,273 $646,000
Q2 2022

Aug 15, 2022

BUY
$8.28 - $13.88 $10,672 - $17,891
1,289 Added 3.95%
33,943 $468,000
Q1 2022

May 16, 2022

SELL
$11.18 - $24.02 $98,931 - $212,552
-8,849 Reduced 21.32%
32,654 $365,000
Q4 2021

Feb 14, 2022

BUY
$20.95 - $26.88 $517,213 - $663,613
24,688 Added 146.82%
41,503 $981,000
Q3 2021

Nov 15, 2021

BUY
$17.26 - $27.08 $290,226 - $455,350
16,815 New
16,815 $429,000
Q2 2021

Aug 11, 2021

SELL
$17.76 - $24.83 $190,724 - $266,649
-10,739 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$13.48 - $23.77 $2,722 - $4,801
202 Added 1.92%
10,739 $252,000
Q4 2020

Feb 16, 2021

SELL
$12.17 - $17.52 $78,143 - $112,495
-6,421 Reduced 37.86%
10,537 $148,000
Q3 2020

Nov 16, 2020

BUY
$11.22 - $14.46 $190,268 - $245,212
16,958 New
16,958 $213,000
Q2 2020

Aug 14, 2020

SELL
$3.59 - $18.57 $69,071 - $357,286
-19,240 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$3.03 - $10.58 $19,701 - $68,791
6,502 Added 51.04%
19,240 $79,000
Q4 2019

Feb 14, 2020

BUY
$5.34 - $9.09 $68,020 - $115,788
12,738 New
12,738 $96,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.28B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.